Micropulse diode laser therapy in refractory glaucoma
Micropulse diode laser therapy in refractory glaucoma
- 眼科实践与研究新进展 2023年3卷第1期 页码：23-28
- 作者机构：
1. ,Casablanca,Morocco
2. ,Casablanca,Morocco
3. ,Niger
- 作者简介：
- 基金信息：
DOI：10.1016/j.aopr.2022.10.003
中图分类号：
扫 描 看 全 文
Micropulse diode laser therapy in refractory glaucoma[J]. 眼科实践与研究新进展, 2023,3(1):23-28.
Moctar Issiaka, Khalil Zrikem, Adil Mchachi, et al. Micropulse diode laser therapy in refractory glaucoma[J]. AOPR, 2023,3(1):23-28.
Micropulse diode laser therapy in refractory glaucoma[J]. 眼科实践与研究新进展, 2023,3(1):23-28. DOI： 10.1016/j.aopr.2022.10.003.
Moctar Issiaka, Khalil Zrikem, Adil Mchachi, et al. Micropulse diode laser therapy in refractory glaucoma[J]. AOPR, 2023,3(1):23-28. DOI： 10.1016/j.aopr.2022.10.003.
摘要
Purpose,Description of safety and efficacy of micropulse Transscleral cyclophotocoagulation as a treatment option for refractory glaucoma.,Methods,This is a prospective study including 39 eyes of 31 patients followed for refractory glaucoma, who benefited from transscleral cyclophotocoagulation using a microplused laser. The main indication for the procedure was increased ocular pressure refractory to quadritherapy in various types of glaucoma. The patients were treated using iridex Cyclo G6 laser with a Micropulse P3 infrared probe with a wavelength of 810 nm. The parameters for the procedure were a duration of 90 s per hemisphere with a power of 2000 mW and an energy of 180 J. Both the upper and lower hemispheres were treated in the same procedure, sparing the 3 o'clock and 9 o'clock meridians, and all the patients benefited from a single treatment session. The following parameters were evaluated: ocular pain and overall tolerance; visual acuity; and the evolution of IOP postoperatively up to 9 months.,Results,The glaucoma subtypes treated are as follows: primary open-angle glaucoma (n = 05), chronic angle-closure glaucoma (n = 13), neovascular glaucoma (n = 07), aphakic glaucoma (n = 06), malignant glaucoma (n = 04), post-traumatic angle recession (n = 02), and inflammatory glaucoma (n = 02). The mean pre-operative intraocular pressure was 42.3 ± 5.2 mmHg and the mean post-operative intraocular pressure at 9 months was 16.9 ± 1.9 mmHg. The reduction in IOP was 49.9%. The average number of intraocular pressure-lowering medications used prior to surgery was four, and the average number of medications used at the 9-month post-operative visit was 2.0 ± 1.2 (70.3% of patients were on dual therapy). The overall success rate was 60.5%.,Conclusions,Micropulse transscleral cyclophotocoagulation appears to be a safe and efficient treatment for refractory glaucoma. Its indications should therefore be broadened and proposed early in various situations.
Abstract
Purpose,Description of safety and efficacy of micropulse Transscleral cyclophotocoagulation as a treatment option for refractory glaucoma.,Methods,This is a prospective study including 39 eyes of 31 patients followed for refractory glaucoma, who benefited from transscleral cyclophotocoagulation using a microplused laser. The main indication for the procedure was increased ocular pressure refractory to quadritherapy in various types of glaucoma. The patients were treated using iridex Cyclo G6 laser with a Micropulse P3 infrared probe with a wavelength of 810 nm. The parameters for the procedure were a duration of 90 s per hemisphere with a power of 2000 mW and an energy of 180 J. Both the upper and lower hemispheres were treated in the same procedure, sparing the 3 o'clock and 9 o'clock meridians, and all the patients benefited from a single treatment session. The following parameters were evaluated: ocular pain and overall tolerance; visual acuity; and the evolution of IOP postoperatively up to 9 months.,Results,The glaucoma subtypes treated are as follows: primary open-angle glaucoma (n = 05), chronic angle-closure glaucoma (n = 13), neovascular glaucoma (n = 07), aphakic glaucoma (n = 06), malignant glaucoma (n = 04), post-traumatic angle recession (n = 02), and inflammatory glaucoma (n = 02). The mean pre-operative intraocular pressure was 42.3 ± 5.2 mmHg and the mean post-operative intraocular pressure at 9 months was 16.9 ± 1.9 mmHg. The reduction in IOP was 49.9%. The average number of intraocular pressure-lowering medications used prior to surgery was four, and the average number of medications used at the 9-month post-operative visit was 2.0 ± 1.2 (70.3% of patients were on dual therapy). The overall success rate was 60.5%.,Conclusions,Micropulse transscleral cyclophotocoagulation appears to be a safe and efficient treatment for refractory glaucoma. Its indications should therefore be broadened and proposed early in various situations.
关键词
Keywords
Micropulse laserTransscleral cyclophotocoagulationRefractory glaucomaIntraocular pressure
references
1 F. ValtotActualités sur les glaucomes réfractaires J Fr Ophtalmol, 26 (HS2) (2003), pp. 56-61
2 AM Tan, M Chockalingam, MC Aquino, et al.Micropulse transscleral diode laser cyclophotocoagulation in the treatment of refractory glaucoma Clin Exp Ophthalmol, 38 (3) (2010), pp. 266-272, 10.1111/j.1442-9071.2010.02238.x
3 A Ma, SWY Yu, JKW Wong, et al.Micropulse laser for the treatment of glaucoma: a literature review Surv Ophthalmol, 64 (4) (2019), pp. 486-497, 10.1016/j.survophthal.2019.01.001
4 MC Aquino, K Barton, AM Tan, et al.Micropulse versus continuous wave transscleral diode cyclophotocoagulation in refractory glaucoma: a randomized exploratory study Clin Exp Ophthalmol, 43 (1) (2015), pp. 40-46, 10.1111/ceo.12360
5 S Sivaprasad, R Sandhu, A Tandon, et al.Subthreshold micropulse diode laser photocoagulation for clinically significant diabetic macular oedema: a three-year follow up Clin Exp Ophthalmol, 35 (7) (2007), pp. 640-644, 10.1111/j.1442-9071.2007.01566.x PMID: 17894684
6 MB Parodi, S Spasse, P Iacono, et al.Subthreshold grid laser treatment of macular edema secondary to branch retinal vein occlusion with micropulse infrared (810 nanometer) diode laser Ophthalmology, 113 (12) (2006), pp. 2237-2242, 10.1016/j.ophtha.2006.05.056 PMID: 16996596
7 TJ Desmettre, SR Mordon, DM Buzawa, et al.Micropulse and continuous wave diode retinal photocoagulation: visible and subvisible lesion parameters Br J Ophthalmol, 90 (6) (2006), pp. 709-712, 10.1136/bjo.2005.086942 PMID: 16531424 PMCID: PMC1860243
8 ML Laursen, F Moeller, B Sander, et al.Subthreshold micropulse diode laser treatment in diabetic macular oedema Br J Ophthalmol, 88 (9) (2004), pp. 1173-1179, 10.1136/bjo.2003.040949 PMID: 15317711 PMCID: PMC1772323
9 CM Moorman, AM HamiltonClinical applications of the micropulse diode laser Eye, 13 (Pt 2) (1999), pp. 145-150, 10.1038/eye.1999.41 PMID: 10450372
10 JS Pollack, JE Kim, JS Pulido, et al.Tissue effects of subclinical diode laser treatment of the retina Arch Ophthalmol, 116 (12) (1998), pp. 1633-1639, 10.1001/archopht.116.12.1633 PMID: 9869794
11 C Hampton, MB Schields, KN Miller, et al.Evaluation of a protocol for transscleral nedymium: YAG cyclophotocoagulation in one hundred patients Ophthalmology, 97 (7) (2002), pp. 910-917, 10.1016/s0161-6420(90)32482-x PMID: 2381706
12 RB Simmon, MB Shield, M Blasini, et al.Transscleral Nd:Yag laser cyclophotocoagulation with contact lens Am J Ophthalmol, 112 (6) (1991), pp. 671-677, 10.1016/s0002-9394(14)77273-3 PMID: 1957902
13 N Gupta, RN WeinrebDiode laser transscleral cyclophotocoagulation J Glaucoma, 6 (6) (1997), pp. 426-429 PMID: 9407372
14 GJ Liu, A Mizukawa, S OkisakaMechanism of intraocular pressure decrease after contact transscleral continuous-wave Nd:YAG laser cyclophotocoagulation Ophthalmic Res, 26 (2) (1994), pp. 65-79, 10.1159/000267395 PMID: 8196935
15 M Johnstone, J MurrayTranscleral Laser Induces Aqueous Outflow Pathway Motion & Reorganization AGS, Coronado, CA (2017) 2017
16 RL Stamper, MF Lieberman, MV DrakeBecker-Shaffer’s Diagnosis and Therapy of the Glaucomas Elsevier Health Sciences (2009), pp. 561-568 https://doi.org/10.1016/B978-0-323-02394-8.00047-4
17 BS Kim, YJ Kim, SW Seo, et al.Long-term results fromcyclocryotherapy applied to the 3o’clock and 9o’clock positions in blind refractory glaucoma patients Kor J Ophthalmol, 29 (1) (2015), pp. 47-52, 10.3341/kjo.2015.29.1.47
18 C RoyerCyclo-affaiblissement transscléral au laser diode dans le traitement des glaucomes réfractaires. Suivi prospectif de 35 patients sur 6 mois Thèse Méd (2002), p. 14 Nancy
19 P Hamard, F May, S Quesnot, et al.La cyclophotocoagulation transsclérale au laser diode dans le traitement des glaucomes réfractaires du sujet jeune J Fr Ophtalmol, 23 (8) (2000), pp. 773-780 JFO-10-2000-23-8-0181-5512-101019-ART6
20 KR Martin, DC BroadwayCyclodiode laser therapy for painful, blind glaucomatous eyes Br J Ophthalmol, 85 (4) (2001), pp. 474-476, 10.1136/bjo.85.4.474
21 A Yelenskiy, TB Gillette, A Arosemena, et al.Patient outcomes following micropulse transcleral photocoagulation intermediate term results J Glaucoma, 27 (10) (2018), pp. 920-925, 10.1097/IJG.0000000000001023
22 AMM Safwat, LM Hammouda, HI El-Zembely, et al.Evaluation of ciliary body by ultrasound bio-microscopy after trans-scleral diode cyclo-photocoagulation in refractory glaucoma Eur J Ophthalmol Janvier, 30 (6) (2020), pp. 1335-1341, 10.1177/1120672119899904
23 Tarib Imane : cyclo-affaiblissement transscleral au laser diode dans le traitement du glaucome refractaire : l’experience du service d’ophtalmologie de l’hmimv, Memoire de specialite, http://ao.um5.ac.ma/xmlui/handle/123456789/18714.
24 ME Emanuel, DS Grover, RL Fellman, et al.Micropulse cyclophotocoagulation: initial results in refractory glaucoma J Glaucoma, 26 (8) (2017), pp. 726-729, 10.1097/IJG.0000000000000715
25 S Sarrafpour, D Saleh, S Ayoub, et al.Micropulse transscleral cyclophotocoagulation: a look at long-term effectiveness and outcomes Ophthalmology Glaucoma, 2 (3) (2019), pp. 167-171, 10.1016/j.ogla.2019.02.002
26 AL Williams, MR Moster, K Rahmatnejad, et al.Clinical efficacy and safety profile of micropulse transscleral cyclophotocoagulation in refractory glaucoma J Glaucoma, 27 (5) (2018), pp. 445-449, 10.1097/IJG.0000000000000934
27 S Kuchar, MR Moster, CB Reamer, et al.Treatment outcomes of micropulse transscleral cyclophotocoagulation in advanced glaucoma Laser Med Sci, 31 (2) (2016), pp. 393-396, 10.1007/s10103-015-1856-9
28 FA Hauber, WJ SchererInfluence of total energy delivery on success rate after contact diode laser transscleral cyclophotocoagulation. A retrospective case review and meta-analysis J Glaucoma, 11 (4) (2002), pp. 329-333, 10.1097/00061198-200208000-00009
29 AT Nguyen, J Maslin, RJ NoeckerEarly results of micropulse transscleral cyclophotocoagulation for the treatment of glaucoma Eur J Ophthalmol, 30 (4) (2020 Jul), pp. 700-705, 10.1177/1120672119839303 PMID: 30938190
30 NB Medow, JM Haley, F LimaInitial ciliary ablation with TSCPC Ophthalmology, 104 (2) (1997), pp. 171-173, 10.1016/s0161-6420(97)38994-5
31 P Hamard, JM Gayraud, J Kopel, et al.Traitement des glaucomes réfractaires par cyclophotocoagulation transsclérale au laser semi-conducteur diode. Analyse de 50 patients suivis pendant 19 mois J Fr Ophtalmol, 20 (2) (1997), pp. 125-133 PMID: 9099271
32 O Kosoko, DE Gaasterland, IP Pollack, et al.Long-term outcome of initial ciliary ablation with contact diode transscleral cyclophotocoagulation for severe glaucoma Ophthalmology, 103 (8) (1996), pp. 1294-1302, 10.1016/s0161-6420(96)30508-3 PMID: 8764801
33 G Rebodella, FJ Munoz, J MurubeAudible pops during cyclodiode procedures J Glaucoma, 8 (3) (1999), pp. 177-183 PMID: 10376257
34 K IshidaUpdate on results and complications of cyclophotocoagulation Curr Opin Ophthalmol, 24 (2) (2013), pp. 102-110, 10.1097/ICU.0b013e32835d9335 PMID: 23313903
0
浏览量
0
下载量
0
CSCD
- Meta-XML下载
- BibTeX下载
- Endnote下载
- RefMan 下载
- NoteExpress下载
- NoteFirst下载
关联资源
相关文章
相关作者
相关机构
- 技术支持由北京北大方正电子有限公司提供 京ICP备09064830号-19
京公网安备11010802024621 - 本系统建议在Chrome、 IE9+ 以上版本浏览器阅读本站内容，360浏览器请切换至极速模式
- Cookies帮助我们提供服务并提供个性化体验。使用本网站，即表示您同意我们使用Cookies